Circulating NAD biosynthetic enzymes (NBEs) as novel prognostic markers in chronic lymphocytic leukemina and Richter's syndrome
Circulating NAD biosynthetic enzymes (NBEs) as novel prognostic markers in chronic lymphocytic leukemina and Richter's syndrome
Tipologia
Progetti internazionali
Ente finanziatore
Gilead Foundation
Budget
€ 25.000,00
Responsabile
Silvia Deaglio
Partecipanti al progetto
- Deaglio Silvia (Responsabile)